M W Fanger Selected Research

PKH 26

11/2000

Production of macrophage-activated killer cells for targeting of glioblastoma cells with bispecific antibody to FcgammaRI and the epidermal growth factor receptor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M W Fanger Research Topics

Disease

2	Neoplasms (Cancer) 02/2001 - 02/2001
1	Autoimmune Diseases (Autoimmune Disease) 12/2001
1	Adenocarcinoma 02/2001
1	Prostatic Neoplasms (Prostate Cancer) 01/2001
1	Carcinoma (Carcinomatosis) 11/2000
1	Glioblastoma (Glioblastoma Multiforme) 11/2000
1	Glioma (Gliomas) 11/2000
1	Infertility (Sterility) 11/2000

Drug/Important Bio-Agent (IBA)

2	MDX-H210 antibodyIBA 02/2001 - 02/2001
1	VaccinesIBA 12/2001
1	Interferon-gamma (Interferon, gamma)IBA 02/2001
1	Fc Receptors (Fc Receptor)IBA 02/2001
1	Superoxides (Superoxide)IBA 02/2001
1	CytokinesIBA 02/2001
1	EnzymesIBA 02/2001
1	Immunoglobulin G (IgG)IBA 02/2001
1	LigandsIBA 01/2001
1	IgG Receptors (Fc gamma RI)IBA 01/2001
1	ErbB Receptors (EGF Receptor)IBA 11/2000
1	EndotoxinsIBA 11/2000
1	PKH 26IBA 11/2000

Therapy/Procedure

1	Therapeutics 12/2001